Relay Therapeutics Inc

25 de set. de 2026, 20:07 UTC

Shares of Relay Therapeutics fell sharply amid retail commentary on FDA-approved lirafugratinib, despite the company not issuing a press release on the matter.

24 de set. de 2026, 19:46 UTC

Relay Therapeutics shares fell amid expectations for data release, despite significant call buying and potential $400 million funding from Elevar if approved this week.

23 de set. de 2026, 23:20 UTC

Relay Therapeutics Inc is gaining in after-market trading, moving from a low return to a peak, currently around the middle of its one-month trading range.

22 de set. de 2026, 20:07 UTC

Relay Therapeutics Inc shares are rising sharply, benefiting from strong market momentum and remaining above their 20-day moving average since Monday's close.

21 de set. de 2026, 20:06 UTC

Relay Therapeutics Inc shares fell sharply, closing near the lower end of their one-month range and significantly below the 20-day moving average.

18 de set. de 2026, 20:06 UTC

Relay Therapeutics Inc shares fell sharply after an early peak, trading below its 20-day moving average and near the lower end of its one-month range.

17 de set. de 2026, 19:46 UTC

Relay Therapeutics Inc is trading higher, having reached a peak earlier before pulling back, and has gained since Wednesday's close.

16 de set. de 2026, 20:13 UTC

Relay Therapeutics Inc saw modestly lower trading during after-market hours, remaining unchanged since Wednesday's close and below its 20-day moving average.

15 de set. de 2026, 19:46 UTC

Relay Therapeutics Inc shares are lower, reflecting negative market sentiment after the NY Empire State Manufacturing Index fell sharply to 7.6 for September.

14 de set. de 2026, 20:21 UTC

Relay Therapeutics Inc. shares advanced in after-market trading, rebounding from earlier lows and reflecting a shift within a routine range since Monday's close.

10 de set. de 2026, 19:16 UTC

Relay Therapeutics Inc is trading higher, recovering from an earlier dip. No specific news was identified, though broader market sentiment may be influencing shares.

9 de set. de 2026, 23:31 UTC

Relay Therapeutics Inc is trading higher in after-market hours, advancing since Wednesday's close despite a broader market decline amid rising oil prices and inflation concerns.

8 de set. de 2026, 20:07 UTC

Relay Therapeutics shares are higher, continuing an upward trend since Friday's close, though they remain below the 20-day moving average.

2 de set. de 2026, 20:08 UTC

Relay Therapeutics will participate in two investor conferences in September 2026. Shares are trading roughly flat since Tuesday's close, below the 20-day moving average.

31 de ago. de 2026, 20:07 UTC

Relay Therapeutics shares are lower today amid broader market pressures and concerns about inflation following the Jackson Hole Economic Symposium.

28 de ago. de 2026, 21:51 UTC

Relay Therapeutics Inc is trading higher in after-market hours, rebounding from three consecutive lower sessions. No specific news was identified for this movement.

27 de ago. de 2026, 22:01 UTC

Relay Therapeutics Inc shares are lower in after-market trading, declining from earlier gains amid broader weakness and three consecutive sessions of losses.

26 de ago. de 2026, 20:08 UTC

Relay Therapeutics Inc is trading lower today amid broader market declines, influenced by inflation data that exceeded expectations and may impact Federal Reserve policy.

25 de ago. de 2026, 23:41 UTC

Relay Therapeutics Inc shares are lower in after-market hours, with no specific news identified for the decline. The stock remains above its 20-day moving average.

24 de ago. de 2026, 19:56 UTC

Relay Therapeutics is testing a buy point at $20.79, reflecting ongoing interest. The stock remains higher since Friday's close despite an earlier pullback.

21 de ago. de 2026, 21:01 UTC

Relay Therapeutics Inc is trading higher in after-market hours, up significantly since Friday's close and above its 20-day moving average.

20 de ago. de 2026, 20:02 UTC

Relay Therapeutics Inc shares are lower today, influenced by a decline in the broader Biotechnology sector and significant market volatility. Trading volume remains unusually high.

19 de ago. de 2026, 23:01 UTC

Relay Therapeutics Inc is trading higher in after-market hours, positioned near the upper end of its one-month range and above its 20-day moving average.

18 de ago. de 2026, 22:26 UTC

Relay Therapeutics Inc. shares traded lower after market hours, reflecting broader market pressure from rising bond yields and inflation concerns.

17 de ago. de 2026, 19:36 UTC

Relay Therapeutics Inc is trading higher amid a Phase 3 trial for its breast cancer treatment and a $53 million investment from Baker Bros.

14 de ago. de 2026, 21:51 UTC

Relay Therapeutics Inc is gaining in after-market trading, supported by social media discussions and a significant portfolio stake from Perceptive Advisors.

13 de ago. de 2026, 19:16 UTC

Relay Therapeutics Inc is trading lower, reflecting broader declines in the biotechnology sector amid fluctuations and rising initial jobless claims.

10 de ago. de 2026, 19:56 UTC

Relay Therapeutics shares are higher after Citizens raised its price target to $26, citing confidence in the company's Phase 3 trials.

7 de ago. de 2026, 20:06 UTC

Barclays raised its price target on Relay Therapeutics to $30.00, contributing to positive sentiment amid ongoing analyst support following the company's Q2 earnings.

6 de ago. de 2026, 23:02 UTC

Relay Therapeutics shares are lower in after-market hours following disappointing Q2 results, including a net loss of $83.7 million and revenue of $350,000.